Granted Patent B2

US 12,673,978 · App. 17/780,188 · Granted Jul 7, 2026

Inventors: Petra Epple; Brody John DeYoung (Research Triangle Park, NC); Holger Schultheiss (Limburgerhof, DE); Ralf Flachmann (Limburgerhof, DE); David A. Hubert (Durham, NC); Anne-Christina Herwig (Limburgerhof, DE)

Assignee: BASF SE

C07K14/415A01H6/20A01H6/46A01H6/54

Abstract

Claims (6)

1 . A method for reducing or delaying Phakopsora infection in a soybean plant, a soybean plant part, or a soybean plant cell, the method comprising:

(1) providing a transgenic soybean plant, transgenic soybean plant part, or transgenic soybean plant cell with an exogenous nucleic acid encoding a Myb41 protein having an amino acid sequence with at least 90% identity with SEQ ID NO. 2 or 5, wherein expression of the Myb41 protein confers increased resistance against Phakopsora thereto in comparison to a wild type soybean plant, wild type soybean plant part or wild type soybean plant cell; and

(2) growing the transgenic soybean plant, transgenic soybean plant part, or transgenic soybean plant cell in the presence of a fungal pathogen of the genus Phakopsora , wherein Phakopsora infection is reduced or delayed in the transgenic soybean plant, transgenic soybean plant part, or transgenic soybean plant cell as compared to a wild type soybean plant, wild type soybean plant part, or wild type soybean plant cell.

2 . The method according to claim 1 , further comprising the step of phosphorylating the Myb41 protein in the respective plant, plant part, or plant cell.

3 . The method according to claim 1 , wherein the Myb41 protein comprises a phosphomimetic mutation.

4 . The method according to claim 1 , wherein the Myb41 protein has an amino acid sequence with at least 95% identity to SEQ ID NO. 2 or 5.

Assignments (4)

Continuity (2)

References Cited (32)